From Bench to Bedside: Modeling Autoimmune, Genetic, and Fibrotic Kidney Diseases in Mice
The development of innovative therapeutics for renal diseases has moved from symptomatic treatments to disease-modifying treatments. To increase the translatability of preclinical data and drug discovery process, GemPharmatech has developed a comprehensive portfolio of kidney disease models recapitulating autoimmune, genetic and fibrotic pathologies for diverse renal disease research, supporting the evaluation of multiple therapeutic modalities, including antibodies, fusion proteins, gene therapy and small molecule compounds.